Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
2001 2
2002 1
2003 4
2004 4
2005 7
2006 12
2007 7
2008 13
2009 26
2010 42
2011 91
2012 74
2013 76
2014 87
2015 82
2016 89
2017 101
2018 116
2019 160
2020 171
2021 208
2022 173
2023 188
2024 96

Text availability

Article attribute

Article type

Publication date

Search Results

1,599 results

Results by year

Filters applied: . Clear all
Page 1
Dravet syndrome.
Lagae L. Lagae L. Curr Opin Neurol. 2021 Apr 1;34(2):213-218. doi: 10.1097/WCO.0000000000000902. Curr Opin Neurol. 2021. PMID: 33395108 Review.
PURPOSE OF REVIEW: This review will illustrate the electroclinical description of Dravet syndrome, highlighting the difficulty to understand the correlation between the SCN1A mutation and clinical characteristics, including the frequent comorbidities. ...Genetic tre …
PURPOSE OF REVIEW: This review will illustrate the electroclinical description of Dravet syndrome, highlighting the difficulty …
Dravet Syndrome: An Overview.
Anwar A, Saleem S, Patel UK, Arumaithurai K, Malik P. Anwar A, et al. Cureus. 2019 Jun 26;11(6):e5006. doi: 10.7759/cureus.5006. Cureus. 2019. PMID: 31497436 Free PMC article. Review.
Dravet syndrome (DS), also known as severe myoclonic epilepsy of infancy (SMEI), is one of the rare early childhood intractable epileptic encephalopathies associated with pleomorphic seizure activity, cognitive decline, motor, and behavioral abnormalities. ...
Dravet syndrome (DS), also known as severe myoclonic epilepsy of infancy (SMEI), is one of the rare early childhood intractabl …
Genetic therapeutic advancements for Dravet Syndrome.
Chilcott E, Díaz JA, Bertram C, Berti M, Karda R. Chilcott E, et al. Epilepsy Behav. 2022 Jul;132:108741. doi: 10.1016/j.yebeh.2022.108741. Epub 2022 May 30. Epilepsy Behav. 2022. PMID: 35653814 Free article. Review.
Dravet Syndrome is a genetic epileptic syndrome characterized by severe and intractable seizures associated with cognitive, motor, and behavioral impairments. ...In this review, we summarize our current knowledge of novel genetic therapies that are currently under d …
Dravet Syndrome is a genetic epileptic syndrome characterized by severe and intractable seizures associated with cognitive, mo …
Dravet Syndrome: A Review of Current Management.
Wheless JW, Fulton SP, Mudigoudar BD. Wheless JW, et al. Pediatr Neurol. 2020 Jun;107:28-40. doi: 10.1016/j.pediatrneurol.2020.01.005. Epub 2020 Jan 31. Pediatr Neurol. 2020. PMID: 32165031 Review.
Dravet syndrome is a debilitating epileptic encephalopathy of childhood with few treatment options available in the United States before 2018. ...Three new medicines-stiripentol, cannabidiol, and fenfluramine-have documented efficacy and safety as adjunctive therapi …
Dravet syndrome is a debilitating epileptic encephalopathy of childhood with few treatment options available in the United Sta …
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S; Cannabidiol in Dravet Syndrome Study Group. Devinsky O, et al. N Engl J Med. 2017 May 25;376(21):2011-2020. doi: 10.1056/NEJMoa1611618. N Engl J Med. 2017. PMID: 28538134 Free article. Clinical Trial.
BACKGROUND: The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a high mortality rate. We studied cannabidiol for the treatment of drug-resistant seizures in the Dravet syndrome. METHODS: In …
BACKGROUND: The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a …
SCN1A Mutation-Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis.
Ding J, Li X, Tian H, Wang L, Guo B, Wang Y, Li W, Wang F, Sun T. Ding J, et al. Front Neurol. 2021 Dec 24;12:743726. doi: 10.3389/fneur.2021.743726. eCollection 2021. Front Neurol. 2021. PMID: 35002916 Free PMC article. Review.
Background: SCN1A is one of the most common epilepsy genes. About 80% of SCN1A gene mutations cause Dravet syndrome (DS), which is a severe and catastrophic epileptic encephalopathy. ...
Background: SCN1A is one of the most common epilepsy genes. About 80% of SCN1A gene mutations cause Dravet syndrome (DS), whic …
Dravet syndrome: Advances in etiology, clinical presentation, and treatment.
He Z, Li Y, Zhao X, Li B. He Z, et al. Epilepsy Res. 2022 Dec;188:107041. doi: 10.1016/j.eplepsyres.2022.107041. Epub 2022 Oct 29. Epilepsy Res. 2022. PMID: 36368227 Review.
Dravet syndrome (DS) is a form of genetic refractory epilepsy. More than 80 % of DS patients carry pathogenic SCN1A mutations, and this percentage is actually higher due to false-negative results in gene testing. ...
Dravet syndrome (DS) is a form of genetic refractory epilepsy. More than 80 % of DS patients carry pathogenic SCN1A mutations, …
Dravet Syndrome as an Example of Precision Medicine in Epilepsy.
Sullivan J, Wirrell EC. Sullivan J, et al. Epilepsy Curr. 2022 Jun 3;23(1):4-7. doi: 10.1177/15357597221106281. eCollection 2023 Jan-Feb. Epilepsy Curr. 2022. PMID: 36923331 Free PMC article. Review.
Dravet syndrome (DS) is a drug-resistant, early-onset, developmental and epileptic encephalopathy where there have been many recently approved therapies with many more in development. ...
Dravet syndrome (DS) is a drug-resistant, early-onset, developmental and epileptic encephalopathy where there have been many r …
Stiripentol for Dravet syndrome.
[No authors listed] [No authors listed] Aust Prescr. 2020 Jun;43(3):102. doi: 10.18773/austprescr.2020.029. Epub 2020 Apr 24. Aust Prescr. 2020. PMID: 32675915 Free PMC article. Review. No abstract available.
Treating Dravet syndrome: a patent landscape.
Miziak B, Czuczwar SJ. Miziak B, et al. Pharm Pat Anal. 2021 Sep;10(5):215-217. doi: 10.4155/ppa-2021-0020. Epub 2021 Sep 7. Pharm Pat Anal. 2021. PMID: 34488475 No abstract available.
1,599 results